1. Home
  2. NAVN vs AMRX Comparison

NAVN vs AMRX Comparison

Compare NAVN & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Navan Inc.

NAVN

Navan Inc.

HOLD

Current Price

$27.78

Market Cap

7.4B

Sector

Technology

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$17.44

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAVN
AMRX
Founded
2015
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
6.2B
IPO Year
2025
2018

Fundamental Metrics

Financial Performance
Metric
NAVN
AMRX
Price
$27.78
$17.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
5
Target Price
$20.92
$15.60
AVG Volume (30 Days)
2.0M
1.6M
Earning Date
05-15-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
157.89
EPS
N/A
0.37
Revenue
$702,265,000.00
N/A
Revenue This Year
$26.56
$4.48
Revenue Next Year
$22.98
$7.13
P/E Ratio
N/A
$48.54
Revenue Growth
30.82
N/A
52 Week Low
$8.11
$9.49
52 Week High
$30.88
$19.26

Technical Indicators

Market Signals
Indicator
NAVN
AMRX
Relative Strength Index (RSI) 49.48 52.16
Support Level $22.15 $16.61
Resistance Level $28.08 $18.58
Average True Range (ATR) 1.24 0.49
MACD -0.38 -0.04
Stochastic Oscillator 34.84 49.53

Price Performance

Historical Comparison
NAVN
AMRX

About NAVN Navan Inc.

Navan Inc is engaged in providing an end-to-end, AI-powered software platform for managing business travel and expense (T&E). The company's platform enables users to manage corporate travel bookings, payments, and expense processes, while providing tools for customers to control and optimize spending and for suppliers to access demand. Geographically, the company operates in the United States, the United Kingdom, and other countries, with the majority of its revenue generated from the United States.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: